Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility.

Marinou I, Walters K, Winfield J, Bax DE, Wilson AG.

Ann Rheum Dis. 2010 Jun;69(6):1191-4. doi: 10.1136/ard.2008.100644. Epub 2009 Aug 26.

PMID:
19713205
[PubMed - indexed for MEDLINE]
2.

Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study.

Orozco G, Eyre S, Hinks A, Ke X; Wellcome Trust Case Control consortium YEAR Consortium, Wilson AG, Bax DE, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Thomson W, Barton A, Worthington J.

Ann Rheum Dis. 2010 May;69(5):813-6. doi: 10.1136/ard.2009.109579. Epub 2009 May 11. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
19435719
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23.

Orozco G, Hinks A, Eyre S, Ke X, Gibbons LJ, Bowes J, Flynn E, Martin P; Wellcome Trust Case Control Consortium; YEAR consortium, Wilson AG, Bax DE, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Thomson W, Barton A, Worthington J.

Hum Mol Genet. 2009 Jul 15;18(14):2693-9. doi: 10.1093/hmg/ddp193. Epub 2009 May 5. Erratum in: Hum Mol Genet. 2010 Nov 15;19(22):4544.

PMID:
19417005
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.

Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Plant D, Gibbons LJ; Wellcome Trust Case Control Consortium; YEAR Consortium; BIRAC Consortium, Wilson AG, Bax DE, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Worthington J.

Nat Genet. 2008 Oct;40(10):1156-9. doi: 10.1038/ng.218. Epub 2008 Sep 14.

PMID:
18794857
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritis.

Marinou I, Walters K, Dickson MC, Binks MH, Bax DE, Wilson AG.

Ann Rheum Dis. 2009 Sep;68(9):1494-7. doi: 10.1136/ard.2008.090001. Epub 2008 Aug 26.

PMID:
18728048
[PubMed - indexed for MEDLINE]
6.

An unusual cause of abnormal liver function in a patient with rheumatoid arthritis.

Boulton JG, Bax DE.

Rheumatology (Oxford). 2008 Feb;47(2):226-7. Epub 2007 Dec 6. No abstract available.

PMID:
18063654
[PubMed - indexed for MEDLINE]
Free Article
7.

The interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritis.

Marinou I, Montgomery DS, Dickson MC, Binks MH, Moore DJ, Bax DE, Wilson AG.

Arthritis Res Ther. 2007;9(2):R40.

PMID:
17442111
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritis.

Low AS, Gonzalez-Gay MA, Akil M, Amos RS, Bax DE, Cannings C, Hajeer A, Till SH, Winfield J, Ollier WE, Wilson AG.

Clin Exp Rheumatol. 2002 Nov-Dec;20(6):829-32.

PMID:
12508775
[PubMed - indexed for MEDLINE]
9.

Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.

Eastell R, Devogelaer JP, Peel NF, Chines AA, Bax DE, Sacco-Gibson N, Nagant de Deuxchaisnes C, Russell RG.

Osteoporos Int. 2000;11(4):331-7.

PMID:
10928223
[PubMed - indexed for MEDLINE]
10.

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.

Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R.

Ann Rheum Dis. 1995 Oct;54(10):801-6.

PMID:
7492217
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Bone mineral density of the hand in rheumatoid arthritis.

Peel NF, Spittlehouse AJ, Bax DE, Eastell R.

Arthritis Rheum. 1994 Jul;37(7):983-91.

PMID:
8024625
[PubMed - indexed for MEDLINE]
12.

Arthritis artefacta: factitious disease in rheumatology.

Amos RS, Bax DE, Bourne JT, Winfield J, Sheehan NJ.

Br J Rheumatol. 1991 Dec;30(6):455-8.

PMID:
1747703
[PubMed - indexed for MEDLINE]
13.

Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy.

Amos RS, Bax DE.

Br J Rheumatol. 1988 Dec;27(6):465-8.

PMID:
2904830
[PubMed - indexed for MEDLINE]
14.

Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.

Amos RS, Pullar T, Bax DE, Situnayake D, Capell HA, McConkey B.

Br Med J (Clin Res Ed). 1986 Aug 16;293(6544):420-3.

PMID:
2874863
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.

Bax DE, Greaves MS, Amos RS.

Br J Rheumatol. 1986 Aug;25(3):282-4.

PMID:
2873862
[PubMed - indexed for MEDLINE]
16.

Sulphasalazine therapy in RA.

Amos RS, Bax DE, Greaves MS.

Ann Rheum Dis. 1986 May;45(5):439. No abstract available.

PMID:
2872858
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Sulphasalazine treatment in rheumatoid arthritis.

Bax DE, Greaves MS, Amos RS.

J Rheumatol. 1986 Apr;13(2):463-4. No abstract available.

PMID:
2873249
[PubMed - indexed for MEDLINE]
18.

Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.

Bax DE, Amos RS.

Ann Rheum Dis. 1986 Feb;45(2):139-40.

PMID:
2868699
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Sulphasalazine in the long term management of rheumatoid arthritis.

Bax DE, Amos RS.

Drugs. 1986;32 Suppl 1:73-6.

PMID:
2877858
[PubMed - indexed for MEDLINE]
20.

Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy.

Amos RS, Bax DE, Greaves MS.

Drugs. 1986;32 Suppl 1:58. No abstract available.

PMID:
2877855
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk